These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 938543)

  • 41. Morphine and phenytoin binding to plasma proteins in renal and hepatic failure.
    Olsen GD; Bennett WM; Porter GA
    Clin Pharmacol Ther; 1975 Jun; 17(6):677-84. PubMed ID: 1095281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma protein binding of thiopental in patients with impaired renal or hepatic function.
    Ghoneim MM; Pandya H
    Anesthesiology; 1975 May; 42(5):545-9. PubMed ID: 1130720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein binding of piretanide in normal and uraemic serum.
    Elliott HL; Ansari AF; Campbell BC; Lawrence JR
    Eur J Clin Pharmacol; 1982; 21(4):311-3. PubMed ID: 7056276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of Ca++ on the binding of drugs to human serum albumin: pharmacokinetic implications.
    Perrin JH; Juni K
    Biopharm Drug Dispos; 1982; 3(4):379-81. PubMed ID: 7159692
    [No Abstract]   [Full Text] [Related]  

  • 45. [Methods of determination and theoretical principles of the serum protein binding of drugs (author's transl)].
    Scholtan W
    Arzneimittelforschung; 1978; 28(7):1037-47. PubMed ID: 385005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of uremia and hemodialysis on the plasma protein binding of tolmetin.
    Pritchard JF; O'Neill PJ; Affrime MB; Lowenthal DT
    Pharmacology; 1984; 29(6):312-9. PubMed ID: 6505005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.
    Keller F; Maiga M; Neumayer HH; Lode H; Distler A
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):275-82. PubMed ID: 6519129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation of the drug-binding defect in plasma from rats with glycerol-induced acute renal failure.
    Bowmer CJ; Lindup WE
    J Pharmacol Exp Ther; 1979 Sep; 210(3):440-5. PubMed ID: 480193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum albumin--a non-saturable carrier.
    Brodersen R; Honoré B; Larsen FG
    Acta Pharmacol Toxicol (Copenh); 1984 Feb; 54(2):129-33. PubMed ID: 6711320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effects of hepatic cirrhosis on the plasma protein binding of drugs.
    García-Morillas M; Gil-Extremera B; Caracuel-Ruiz MD
    Int J Clin Pharmacol Res; 1984; 4(5):327-33. PubMed ID: 6519849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimation of the plasma protein binding of drugs by size exclusion chromatography at medium pressure (150 lb in-2: 1-03 MPa).
    Morris MJ; Brown JR
    J Pharm Pharmacol; 1977 Oct; 29(10):642-4. PubMed ID: 21250
    [No Abstract]   [Full Text] [Related]  

  • 52. Influence of free fatty acid concentration on drug binding to plasma albumin.
    Spector AA; Santos EC; Ashbrook JD; Fletcher JE
    Ann N Y Acad Sci; 1973 Nov; 226():247-58. PubMed ID: 4520396
    [No Abstract]   [Full Text] [Related]  

  • 53. [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].
    Tillement JP; Duché JC; Barré J
    Bull Acad Natl Med; 2006; 190(4-5):935-46; discussion 946-7. PubMed ID: 17195618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased plasma protein binding of diazoxide in uremia.
    O'Malley K; Velasco M; Pruitt A; McNay JL
    Clin Pharmacol Ther; 1975 Jul; 18(1):53-8. PubMed ID: 1149362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aromatic amino acid metabolites as potential protein binding inhibitors in human uremic plasma.
    Tavares-Almeida I; Gulyassy PF; Depner TA; Jarrard EA
    Biochem Pharmacol; 1985 Jul; 34(14):2431-8. PubMed ID: 4015686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug binding to plasma proteins.
    Paxton JW
    N Z Med J; 1985 Apr; 98(776):245-8. PubMed ID: 3857503
    [No Abstract]   [Full Text] [Related]  

  • 57. Decreased drug binding in serum from patients with chronic hepatic disease.
    Wallace S; Brodie MJ
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):429-32. PubMed ID: 971706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of binding on drug metabolism and distribution.
    Dayton PG; Israili ZH; Perel JM
    Ann N Y Acad Sci; 1973 Nov; 226():172-94. PubMed ID: 4588440
    [No Abstract]   [Full Text] [Related]  

  • 59. Isolation and chemical characterization of 2-hydroxybenzoylglycine as a drug binding inhibitor in uremia.
    Lichtenwalner DM; Suh B; Lichtenwalner MR
    J Clin Invest; 1983 May; 71(5):1289-96. PubMed ID: 6853715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Endogenous metabolites as modulators of the transport of drugs by serum albumin].
    Bender KI; Lutsevich NF; Lutsevich AN; Kupchikov VV
    Farmakol Toksikol; 1990; 53(3):72-80. PubMed ID: 2201566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.